You are here: All Products  > BioCity Plans Trial of TIM-3 mAb with AstraZeneca’s PD-L1 for Liver Cancer

BioCity Plans Trial of TIM-3 mAb with AstraZeneca’s PD-L1 for Liver Cancer

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products